Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
01 Improved glycemic control Tirzepatide's dual action on GIP and GLP-1 receptors, combined with cagrilintide's effects on glucose metabolism, could result in better management of blood sugar levels
The highest dose of 4.5 mg produced an average weight loss of 11.5 kg, roughly 25 pounds, in just 26 weeks
For a full look at IV, injection, and program options, visit our NAD+ therapy in Sioux Falls page
Safety, Side Effects & Regulatory Notes Early research suggests BPC-157 is well-tolerated in animals and limited human studies, but long-term effects remain unknown
US$ 22.73
US$ 28.86
US$ 27.46
US$ 25.89
